ARCHIV DER PHARMAZIE - Journal - Bridge of Knowledge

Search

ARCHIV DER PHARMAZIE

ISSN:

0365-6233

eISSN:

1521-4184

Disciplines
(Field of Science):

  • medical biology (Medical and Health Sciences )
  • pharmacology and pharmacy (Medical and Health Sciences )
  • medical sciences (Medical and Health Sciences )
  • health sciences (Medical and Health Sciences )
  • biotechnology (Natural sciences)
  • chemical sciences (Natural sciences)

Ministry points: Help

Ministry points - current year
Year Points List
Year 2024 70 Ministry scored journals list 2024
Ministry points - previous years
Year Points List
2024 70 Ministry scored journals list 2024
2023 70 Ministry Scored Journals List
2022 70 Ministry Scored Journals List 2019-2022
2021 70 Ministry Scored Journals List 2019-2022
2020 70 Ministry Scored Journals List 2019-2022
2019 70 Ministry Scored Journals List 2019-2022
2018 20 A
2017 20 A
2016 20 A
2015 20 A
2014 20 A
2013 20 A
2012 20 A
2011 20 A
2010 27 A

Model:

Hybrid

Points CiteScore:

Points CiteScore - current year
Year Points
Year 2022 6.9
Points CiteScore - previous years
Year Points
2022 6.9
2021 5.4
2020 4.1
2019 3.6
2018 3.7
2017 3.8
2016 3.8
2015 3.5
2014 3
2013 3.1
2012 2.9
2011 3.1

Impact Factor:

Log in to see the Impact Factor.

Filters

total: 1

  • Category
  • Year
  • Options

clear Chosen catalog filters disabled

Catalog Journals

Year 2024
  • Quinoline-based thiazolyl-hydrazones target cancer cells through autophagy inhibition
    Publication
    • V. Ćurčić
    • M. Olszewski
    • N. Maciejewska
    • A. Višnjevac
    • T. Srdić-rajić
    • V. Dobričić
    • A. T. García-sosa
    • S. B. Kokanov
    • J. B. Araškov
    • R. Silvestri... and 4 others

    - ARCHIV DER PHARMAZIE - Year 2024

    Heterocyclic pharmacophores such as thiazole and quinoline rings have a significant role in medicinal chemistry. They are considered privileged structures since they constitute several Food and Drug Administration (FDA)-approved drugs for cancer treatment. Herein, we report the synthesis, in silico evaluation of the ADMET profiles, and in vitro investigation of the anticancer activity of a series of novel thiazolyl-hydrazones based...

    Full text to download in external service

seen 120 times